Matrix regenerative nanotherapeutics for small abdominal aortic aneurysm repair
用于修复小腹主动脉瘤的基质再生纳米疗法
基本信息
- 批准号:10281418
- 负责人:
- 金额:$ 36.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-12-15 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:Abdominal Aortic AneurysmActive SitesAdultAnabolismAnimal ModelAortaAortic DiseasesApoptosisAttenuatedBiodistributionBiomimeticsCaliberCathetersCationsCell Culture TechniquesCellsChargeChronicClinical TrialsCollagen FiberComplement Factor BDataDiagnosisDoseDoxycyclineElastic FiberElastinElderlyEnzymesEtiologyEventExtracellular MatrixExtracellular StructureFiberFormulationFutureGlycolatesGrowthHomeostasisHydrophobicityImageInfusion proceduresLinkLiteratureMAPK8 geneMMP2 geneMagnetismMediatingMessenger RNAMetalloproteasesModelingMusOperative Surgical ProceduresOralOutcomePatientsPharmaceutical PreparationsPharmacotherapyPolymersPropertyProtein IsoformsRattusRuptureSP600125SafetySeveritiesSignal TransductionSmokerSmooth Muscle MyocytesSpecificityStimulusStretchingStructureSurfaceSystemTestingTimeTissuesTransforming Growth Factor betaTransforming Growth FactorsTreatment EfficacyVascular DiseasesVascular Smooth Muscleabdominal aortaacyl groupbiodegradable polymercrosslinkdensitydesignflexibilityhigh riskinhibitor/antagonistinjurediron oxide nanoparticlemaleminimally invasivenanoparticlenanoparticle deliverynanosizednanotherapeuticnanotherapyolder patientoverexpressionparticlepre-clinicalpreventprospectiveregenerativeregenerative repairrepairedrestorationside effectstress activated protein kinasesynergismuptake
项目摘要
Abstract
Our objective is to investigate a new, minimally-invasive regenerative nanotherapy to arrest or regress
growth of small (<5.5 cm diameter) abdominal aortic aneurysms (AAAs). AAAs are localized expansions of the
abdominal aorta that ultimately rupture. Early surgery on small AAAs provides no treatment benefit and no
other proven therapies exist. While reinstating homeostasis of the structural extracellular matrix (ECM;
collagen and elastic fibers) in the AAA wall is critical to stop or reverse AAA growth, this is impeded by a) their
chronic breakdown in the aorta wall by upregulated matrix metalloprotease (MMPs) enzymes and b) lack of
approaches to overcome intrinsically deficient and defective elastic fiber regenerative repair by adult vascular
smooth muscle cells (SMCs). Oral dosing of doxycycline (DOX) has been shown to inhibit MMPs in the AAA
wall to slow AAA growth, but has systemic side effects and inhibits elastin biosynthesis at the high doses. To
avoid this, we have formulated biodegradable polylactic-co- glycolic acid (PLGA) nanoparticles (NPs) for
steady, sustained release of doxycycline (DOX), an MMP inhibitor within the AAA wall following one-time,
catheter-wise infusion to a transiently flow-occluded AAA segment. At the much lower release levels (<10
μg/ml), DOX was found to maintain its MMP inhibitory effects, but also to beneficially stimulate elastic matrix
neoassembly (elastogenesis). We also uniquely surface-functionalized our NPs with cationic amphiphiles that
have pro-elastogenic & anti-proteolytic separate from the effects of the released DOX. Building on this
promising preliminary data, we now propose to confirm the signaling mechanisms underlying the unique pro-
matrix regenerative and anti-MMP effects of DOX at sub-oral doses, identify DOX-NP formulations that provide
a significant stimulus to biomimetic and stable elastic fiber assembly, design and test a magnetic guidance
system for efficient NP delivery to the AAA wall, and demonstrate efficacy of the DOX-NPs in regressing
already formed small AAAs in a preclinical (rat) model. Our aims will test hypotheses that 1) pro-elastogenic
effects of DOX are mediated by JNK decreases which trigger increases in TGF-β1, 2) quantity and quality of
elastic fiber assembly can be regulated by modulating severity of JNK inhibition by DOX, 3) DOX is more
effective than SP600125 (at their IC50 doses for JNK) in stimulating elastin since it also directly inactivates
MMPs, and 4) regenerative stimuli due to DOX-NPs will restore matrix homeostasis in the AAA wall to arrest its
growth. Aim 1 will correlate severity of DOX inhibition of JNK to downstream elastogenesis and anti-MMP
outcomes in rat AAA SMC cultures. Aim 2 will generate DOX-NP formulations with superior pro-elastogenic &
matrix reparative properties. Aim 3 will develop a magnetic system to target DOX-NPs to the AAA wall in a rat
model. Aim 4 will assess therapeutic efficacy of magnetically-responsive DOX-NPs in rat AAAs. If successful,
our approach will be validated in larger animal models to rationalize future clinical trials. Our approach can
prospectively reduce or delay need for future surgery in high risk elderly AAA patients.
抽象的
我们的目的是调查一种新的,微创的再生纳米疗法以逮捕或退化
腹主动脉瘤(AAAS)的小(直径<5.5 cm)的生长。 AAA是局部扩展
腹主动脉最终破裂。小型AAA的早期手术没有治疗益处,也没有
还有其他经过验证的疗法。同时恢复结构性细胞外基质(ECM;
AAA壁中的胶原蛋白和弹性纤维)对于停止或逆转AAA的生长至关重要,这受到A)的阻碍
通过上调的基质金属蛋白酶(MMP)酶在主动脉壁中的慢性分解和b)缺乏
通过成年血管克服本质上确定和有缺陷的弹性纤维再生修复的方法
平滑肌细胞(SMC)。表明强力霉素(DOX)的口服剂量抑制AAA中的MMP
壁以减慢AAA的生长,但具有全身性副作用并抑制高剂量的弹性蛋白生物合成。到
避免这种情况,我们已经制定了可生物降解的聚乳酸 - 乙醇酸(PLGA)纳米颗粒(NPS)
一次稳定,持续释放多西环素(DOX),一次是AAA墙内的MMP抑制剂
将导管的瞬时流动aAA段输注。在低得多的发行级别(<10
发现μg/ml),发现DOX可以维持其MMP抑制作用,但也有益地刺激弹性矩阵
新组装(弹性发生)。我们还用阳离子两亲的NP唯一地将其表面函数化
具有促载体和抗蛋白质水解与释放的DOX的作用分开。基于此
有希望的初步数据,我们现在建议确认唯一pro的信号传导机制
DOX在次剂量下的基质再生和抗MMP效应,识别提供的DOX-NP公式
仿生和稳定弹性纤维组件的显着刺激,设计和测试磁引导
有效的NP向AAA墙传递的系统,并证明了DOX-NP的效率
已经在临床前(大鼠)模型中形成了小的AAA。我们的目标将检验假设1)促载体
DOX的效果是由JNK介导的,在TGF-β1中触发的增加,2)数量和质量
弹性纤维组件可以通过调节DOX的JNK抑制严重程度来调节,3)DOX更多
在刺激弹性蛋白中,比SP600125(以JNK的IC50剂量为JNK)有效,因为它也直接失活
MMP和4)由于DOX-NP引起的再生刺激将恢复AAA墙中的基质稳态以逮捕其
生长。 AIM 1将将JNK的DOX抑制严重程度与下游弹性发生和抗MMP相关
大鼠AAA SMC文化的结果。 AIM 2将产生具有优质启发性&的DOX-NP公式
矩阵修复属性。 AIM 3将开发磁系统将DOX-NP靶向大鼠的AAA壁
模型。 AIM 4将评估大鼠AAA中磁响应的DOX-NP的治疗效率。如果成功,
我们的方法将在较大的动物模型中得到验证,以合理化未来的临床试验。我们的方法可以
前瞻性地减少或延迟需要在AAA患者的高风险中对未来手术的需求。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Adult Mesenchymal Stem Cells and Derivatives in Improved Elastin Homeostasis in a Rat Model of Abdominal Aortic Aneurysms.
- DOI:10.1093/stcltm/szac043
- 发表时间:2022-08-23
- 期刊:
- 影响因子:6
- 作者:Dahal, Shataakshi;Dayal, Simran;Androjna, Charlie;Peterson, John;Ramamurthi, Anand
- 通讯作者:Ramamurthi, Anand
Sodium Nitroprusside Stimulation of Elastic Matrix Regeneration by Aneurysmal Smooth Muscle Cells
- DOI:10.1089/ten.tea.2022.0169
- 发表时间:2023-02-27
- 期刊:
- 影响因子:4.1
- 作者:Bastola,Suraj;Kothapalli,Chandrasekhar;Ramamurthi,Anand
- 通讯作者:Ramamurthi,Anand
Assessing the targeting and fate of cathepsin k antibody-modified nanoparticles in a rat abdominal aortic aneurysm model
- DOI:10.1016/j.actbio.2020.05.037
- 发表时间:2020-08-01
- 期刊:
- 影响因子:9.7
- 作者:Camardo, Andrew;Carney, Sarah;Ramamurthi, Anand
- 通讯作者:Ramamurthi, Anand
Multifunctional, JNK-inhibiting nanotherapeutics for augmented elastic matrix regenerative repair in aortic aneurysms.
- DOI:10.1007/s13346-017-0419-y
- 发表时间:2018-08
- 期刊:
- 影响因子:5.4
- 作者:Camardo A;Seshadri D;Broekelmann T;Mecham R;Ramamurthi A
- 通讯作者:Ramamurthi A
Surface-Functionalized Stem Cell-Derived Extracellular Vesicles for Vascular Elastic Matrix Regenerative Repair.
- DOI:10.1021/acs.molpharmaceut.2c00769
- 发表时间:2023-06-05
- 期刊:
- 影响因子:4.9
- 作者:Sajeesh, S.;Camardo, Andrew;Dahal, Shataakshi;Ramamurthi, Anand
- 通讯作者:Ramamurthi, Anand
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANAND RAMAMURTHI其他文献
ANAND RAMAMURTHI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANAND RAMAMURTHI', 18)}}的其他基金
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys
细胞介导的弹性蛋白基质再生稳定主动脉瘤的线索
- 批准号:
7760576 - 财政年份:2009
- 资助金额:
$ 36.23万 - 项目类别:
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys
细胞介导的弹性蛋白基质再生稳定主动脉瘤的线索
- 批准号:
7834746 - 财政年份:2009
- 资助金额:
$ 36.23万 - 项目类别:
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys
细胞介导的弹性蛋白基质再生稳定主动脉瘤的线索
- 批准号:
8099190 - 财政年份:2009
- 资助金额:
$ 36.23万 - 项目类别:
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys
细胞介导的弹性蛋白基质再生稳定主动脉瘤的线索
- 批准号:
7580459 - 财政年份:2009
- 资助金额:
$ 36.23万 - 项目类别:
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys
细胞介导的弹性蛋白基质再生稳定主动脉瘤的线索
- 批准号:
8099191 - 财政年份:2009
- 资助金额:
$ 36.23万 - 项目类别:
Cues for cell-mediated regeneration of elastin matrix to stabilize aortic aneurys
细胞介导的弹性蛋白基质再生稳定主动脉瘤的线索
- 批准号:
8021848 - 财政年份:2009
- 资助金额:
$ 36.23万 - 项目类别:
Cues for cell-mediated regeneration of elastin matrix in aortic aneurysms
主动脉瘤中细胞介导的弹性蛋白基质再生的线索
- 批准号:
8225232 - 财政年份:2009
- 资助金额:
$ 36.23万 - 项目类别:
Hyaluronan Scaffold for Regenerating Elastin Matrices
用于再生弹性蛋白基质的透明质酸支架
- 批准号:
7196137 - 财政年份:2007
- 资助金额:
$ 36.23万 - 项目类别:
Hyaluronan Scaffold for Regenerating Elastin Matrices
用于再生弹性蛋白基质的透明质酸支架
- 批准号:
7342012 - 财政年份:2007
- 资助金额:
$ 36.23万 - 项目类别:
TESTING INFLAMMATORY POTENTIAL OF HYALURONAN-DERIVED VASCULAR IMPLANTS
测试透明质酸衍生血管植入物的炎症潜力
- 批准号:
7607154 - 财政年份:2007
- 资助金额:
$ 36.23万 - 项目类别:
相似海外基金
Dissecting the Determinants of IDH-mutant Gliomas Response to Mutant IDH Inhibitors
剖析 IDH 突变型胶质瘤对突变 IDH 抑制剂反应的决定因素
- 批准号:
10734393 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
Local translation and viral infection in the airway epithelium
气道上皮的局部翻译和病毒感染
- 批准号:
10736284 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
纤维板层肝细胞癌的新抗原特异性 T 细胞反应
- 批准号:
10609918 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
心力衰竭的新型疗法:修饰的水溶性 Caveolin-1 支架结构域肽,具有改进的药物开发特性
- 批准号:
10599654 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别:
Functionalized Multi-Modal Tetrode Arrays for Real-Time, Site-Specific Neurochemical Monitoring
用于实时、特定部位神经化学监测的功能化多模态 Tetrode 阵列
- 批准号:
10759908 - 财政年份:2023
- 资助金额:
$ 36.23万 - 项目类别: